MINI FUTURE LONG ZERTIFIKAT MIT SL - ROCHE Share Price

Certificat

DE000NG8Q932

Real-time Boerse Frankfurt Warrants 02:45:08 16/07/2024 pm IST
15.44 EUR -0.96% Intraday chart for MINI FUTURE LONG ZERTIFIKAT MIT SL - ROCHE
Current month+5.34%
1 month+5.05%
Date Price Change
16/24/16 15.44 -0.96%
15/24/15 15.59 +2.23%
12/24/12 15.25 +2.56%
11/24/11 14.87 0.00%
10/24/10 14.87 +4.50%

Real-time Boerse Frankfurt Warrants

Last update July 16, 2024 at 02:45 pm IST

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer ING Bank
WKN NG8Q93
ISINDE000NG8Q932
Date issued 15/05/2024
Strike 132.9 CHF
Maturity Unlimited
Parity 10 : 1
Emission price 11.39
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 15.88
Lowest since issue 11.74
Spread 0.08
Spread %0.52%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
258.7 CHF
Average target price
274 CHF
Spread / Average Target
+5.91%
Consensus